| Literature DB >> 15351784 |
Akihiko Hoshino1, Takemasa Tsuji, Junko Matsuzaki, Takafumi Jinushi, Shigeru Ashino, Takashi Teramura, Kenji Chamoto, Yoshitaka Tanaka, Yumiko Asakura, Takanobu Sakurai, Yasuo Mita, Akiko Takaoka, Shiro Nakaike, Tsuguhide Takeshima, Hiroaki Ikeda, Takashi Nishimura.
Abstract
When wild-type BALB/c mice were transferred with OVA-specific Th2 cells followed by OVA inhalation, a severe eosinophilia, mucus hypersecretion and airway hyper-responsiveness (AHR) was induced in parallel with a marked elevation of IL-4, IL-5 and IL-13 levels in bronchoalveolar lavage fluid (BALF). However, neither eosinophilia, AHR nor mucus hypersecretion was induced in Th2 cell-transferred STAT6-/- mice. The failure of eosinophilia was not due to the defect of Th2 cytokine production in BALF of STAT6-/- mice transferred with Th2 cells, but because of the defect of STAT6-dependent eotaxin production. Indeed, intranasal administration of eotaxin reconstituted pulmonary eosinophilia but not AHR and mucus hypersecretion in OVA-inhalated STAT6-/- mice. These results initially provided direct evidence that STAT6-dependent eotaxin production is essential for pulmonary eosinophilia. We also dissociated the role of STAT6 for eosinophilia from that for AHR and mucus hypersecretion. Thus, STAT6 also plays a critical role at late phase of Th2-dependent allergy induction.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15351784 DOI: 10.1093/intimm/dxh151
Source DB: PubMed Journal: Int Immunol ISSN: 0953-8178 Impact factor: 4.823